DDrare: Database of Drug Development for Rare Diseases

Searched query = "Congenital diaphragmatic hernia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Autologous umbilical cord blood; Bronchodilator Response; Diagnostic Test: Fecal microbiome probiotic; Diagnostic Test: Functional residual capacity; Diagnostic Test: Maximum oxygen uptake; Diagnostic Test: Pulmonary microbiome probiotic; Diagnostic Test: VOC probiotic; Diagnostic Test: initial VOC; Diagnostic Test: initial fecal microbiome; Diagnostic Test: initial pulmonary microbiome; Gold; Hypersaline; INOmax; INOmax 800ppm mol/mol inhalatiegas; Inomax; Losec; Milrinone; NITRIC OXIDE; Neophyr 1000ppm mol/mol; Nitric Oxide; Omeprazol; Omeprazole; Omeprazole rectally 1mg/kg; Oxygen; Probiotic treatment; Procedure: Repair of CDH w/Alloderm; Procedure: Repair of CDH w/SIS Gold; Revatio 0.8mg/ml solution for injection; Sildenafil

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-002026-22-NL (EUCTR)	24/10/2013	27/06/2013	Adminstration of omeprazole by rectiole or oral tablet for the treatment of reflux disease in neonates and infants with a closure of the esophagus or a congenital opening in the diaphragm.	Rectal and oral omeprazole treatment of gastroesophageal reflux in infants with esophageal atresia or congenital diaphragmatic hernia.A pharmacodynamic and pharmacokinetic study - NEOPREMEC	GORD,;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Trade Name: Losec Product Name: Omeprazol Product Code: NA Trade Name: Losec Product Name: Omeprazol Product Code: NA	ErasmusMC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands
2	NCT00226044 (ClinicalTrials.gov)	September 2005	22/9/2005	Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.	Rectal and Oral Omeprazole Treatment of Gastroesophageal Reflux in Infants With Esophageal Atresia or Congenital Diaphragmatic Hernia; A Pharmacodynamic and Pharmacokinetic Study.	Gastroesophageal Reflux;Esophageal Atresia;Hernia, Diaphragmatic	Drug: Omeprazole rectally 1mg/kg	Rijnstate Hospital	Erasmus Medical Center	Completed	6 Weeks	3 Months	All	17	Phase 3	Netherlands

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

EUCTR2013-002026-22-NL
(EUCTR)

24/10/2013

27/06/2013

Adminstration of omeprazole by rectiole or oral tablet for the treatment of reflux disease in neonates and infants with a closure of the esophagus or a congenital opening in the diaphragm.

Rectal and oral omeprazole treatment of gastroesophageal reflux in infants with esophageal atresia or congenital diaphragmatic hernia.A pharmacodynamic and pharmacokinetic study - NEOPREMEC

GORD,;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]

Trade Name: Losec
Product Name: Omeprazol
Product Code: NA
Trade Name: Losec
Product Name: Omeprazol
Product Code: NA

ErasmusMC

NULL

Authorised-recruitment may be ongoing or finished

Female: yes
Male: yes

Netherlands

NCT00226044
(ClinicalTrials.gov)

September 2005

22/9/2005

Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.

Rectal and Oral Omeprazole Treatment of Gastroesophageal Reflux in Infants With Esophageal Atresia or Congenital Diaphragmatic Hernia; A Pharmacodynamic and Pharmacokinetic Study.

Gastroesophageal Reflux;Esophageal Atresia;Hernia, Diaphragmatic

Drug: Omeprazole rectally 1mg/kg

Rijnstate Hospital

Erasmus Medical Center

Completed

6 Weeks

3 Months

All

Phase 3

Netherlands